Angelika Bierhaus

Title: Angelika Bierhaus: Innovator in Pain Treatment

Introduction

Angelika Bierhaus is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of pain management through her innovative research and development of novel compounds. Her work focuses on the prevention and treatment of pain and hyperalgesia, particularly related to reactive carbonyl species.

Latest Patents

Angelika Bierhaus holds a patent for "Methylglyoxal-scavenging compounds and their use for the prevention and treatment of pain and/or hyperalgesia." This invention relates to compounds that inhibit or antagonize the binding of methylglyoxal and other reactive carbonyl species to proteins, particularly sodium ion channels. The preferred scavenger compounds are peptides that include multiple repeats of the amino acid sequence motif Gly-Glu-X-Pro, where X is either Arg or Lys. These compounds are designed to be used in pharmaceutical compositions for treating pain and hyperalgesia associated with methylglyoxal and related reactive carbonyl species.

Career Highlights

Angelika Bierhaus is affiliated with Ruprecht-Karls-Universität Heidelberg, where she conducts her research. Her work has led to advancements in understanding the mechanisms of pain and the development of therapeutic strategies to alleviate it. She has been recognized for her innovative approach to addressing complex medical challenges.

Collaborations

Angelika has collaborated with notable colleagues, including Thomas H. Fleming and Peter P. Nawroth. These collaborations have further enriched her research and contributed to the advancement of her patented technologies.

Conclusion

Angelika Bierhaus is a trailblazer in the field of pain treatment, with her innovative compounds offering new hope for patients suffering from pain and hyperalgesia. Her contributions to science and medicine continue to make a significant impact.